Skip to main content
. 2019 Aug 31;146(11):2968–2978. doi: 10.1002/ijc.32629

Table 3.

Patient characteristics of the observational NCR cohort

Variable Whole population (n = 1,947) Untreated (n = 1,833) Treated (n = 114) t‐test p‐value treated/untreated Untreated match 11 (n = 76) Treated match 11 (n = 76) Untreated match 22 (n = 113) Treated match 22 (n = 113)
Age (years) 70.9 (11.0) 71.5 (10.8) 61.7 (10.6) <0.01 64.0 (8.2) 64.0 (8.2) 59.5 (11.6) 61.9 (10.0)
pT stage
T3 1,753 (90.0) 1,678 (91.5) 75 (65.8) <0.01 68 (89.5) 68 (89.5) 85 (75.2) 75 (66.4)
T4 194 (10.0) 155 (8.5) 39 (34.2) 8 (10.5) 8 (10.5) 28 (24.8) 38 (33.6)
Number of evaluated lymph nodes
<10 1,050 (53.9) 975 (53.2) 75 (65.8) 0.01 57 (75.0) 57 (75.0) 82 (72.6) 75 (66.4)
≥10 897 (46.1) 858 (46.8) 39 (34.2) 19 (25.0) 19 (25.0) 31 (27.4) 38 (33.6)
Tumor site
Right 1,173 (60.2) 1,106 (60.3) 67 (58.8) 0.82 43 (56.6) 43 (56.6) 65 (57.5) 67 (59.3)
Left 774 (39.8) 727 (39.7) 47 (41.2) 33 (43.4) 33 (43.4) 48 (42.5) 46 (40.7)
Tumor differentiation
Well/moderate 1,623 (83.3) 1,543 (84.2) 80 (70.2) <0.01 58 (76.3) 58 (76.3) 89 (78.8) 79 (69.9)
Poor/not 324 (16.7) 290 (15.8) 34 (29.8) 18 (23.7) 18 (23.7) 24 (21.2) 34 (30.1)

Data are presented as means (±SD) or numbers (%).

1

Match 1 is the matching sample with caliper score of 0.

2

Match 2 is the matching sample with caliper score of 0.2 multiplying by standard deviation of the logit propensity score.